NM_002485.5:c.1089C>A
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_002485.5(NBN):c.1089C>A(p.Tyr363*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Y363Y) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_002485.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Nijmegen breakage syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health
 - rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
 - idiopathic aplastic anemiaInheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
 - prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
 - hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 32 
GnomAD2 exomes  AF:  0.00000398  AC: 1AN: 251406 AF XY:  0.00000736   show subpopulations 
GnomAD4 exome  AF:  0.00000137  AC: 2AN: 1461766Hom.:  0  Cov.: 32 AF XY:  0.00000138  AC XY: 1AN XY: 727190 show subpopulations 
Age Distribution
GnomAD4 genome  Cov.: 32 
ClinVar
Submissions by phenotype
Microcephaly, normal intelligence and immunodeficiency    Pathogenic:3Other:1 
For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 6947). This premature translational stop signal has been observed in individual(s) with clinical features of Nijmegen breakage syndrome who were homozygous for the variant (PMID: 12447395, 15593232). This variant is present in population databases (rs121908974, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Tyr363*) in the NBN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NBN are known to be pathogenic (PMID: 9590180, 16415040). -
- -
- -
Variant summary: NBN c.1089C>A (p.Tyr363X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4e-06 in 251406 control chromosomes (gnomAD). c.1089C>A has been reported in the literature in multiple homozygous individuals affected with Nijmegen Breakage Syndrome and the variant segregated with the disease (examples: Nakanishi_2002 and New_2005). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein. Using immunoblotting Nakanishi_2002 have demonstrated that this variant results in complete absence of the protein. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Aplastic anemia    Pathogenic:1 
- -
not provided    Pathogenic:1 
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies demonstrate complete loss of NBN protein (Nakanishi et al., 2002); This variant is associated with the following publications: (PMID: 25525159, 18575580, 15451479, 30287823, 15593232, 29922827, 33082212, 35767752, 16033915, 12447395) -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at